Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma
2 Просмотры
• 07/17/23
0
0
встраивать
administrator
Подписчики
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.
Показать больше
Комментарии Facebook
SORT BY-
Лучшие комментарии
-
Последние комментарии